95 

 - 1 9 3 9 - 

 0.6^ nitrogen and 60^ reducing substances. 



83, IVANOVICS, G. 



Das Schlcksal der Kapselsubstanz der Mllzbrandbaclllen im 

 Organlsmus (Fate of the anthrax bacillus capsular substance In the 

 organism) 



Ztschro f. Immunltatsforschung, u. Exp, Therap. 96:4o8-4l2, 1939 



34. IVY, A. C. and GRAY, J. S. 



The application of recent contributions in basic medical sciences 

 to surgical practice. Reactions to intravenous therapy 



Inter, Abstr, Surg. 69:4l4-4l6, 1939 



A brief review of major milestones in the literature of pyrogens 

 since I9II. 



285. MASUCCI, P. 



Antigenic polysaccharide complex from cocci 



U. S. Patent #2,166,963, July 25, 1939 



A method of extracting and precipitating antigenic polysaccharides 

 from cocci. 



586, MIELNIK-KOSMIDERSKI, S. 



fiber Der Elnflussung der Phagozytose durch die Bakterienkapsel 

 und Bakterlelle Polysaccharide (Influence of phagocytosis of 

 bacterial capsule and bacterial polysaccharide) 



Ztschr. f . Immunitatsforshung, u. Exp. Therap. 95:203-217, 1939 



Free or somatic polysaccharide from the capsule of scleroma bac- 

 teria enhances phagocytosis of uncapsulated bacteria to a degree 

 limited by the number of bacteria and of leukocytes. Very small 

 amounts of polysaccharides decrease phagocytosis below normal 

 levels. The amount of polysaccharide released around bacteria by 

 antibody may increase (or decrease) phagocytosis. 



287, MORGAN, H. R, and BECKWITH, T. D. 



Immunological relationships of polysaccharides of mucoid organisms 

 of typhoid -salmonella groups 



